Kerala has intensified its efforts to establish itself as a leading hub for life sciences and biomedical industries, securing investment pledges worth Rs 713 crore through an international conclave hosted by the state-owned Kerala State Industrial Development Corporation (KSIDC). The event 'Bio Connect 4.0' held for two days concluded on Friday (October 9). During the event, three memorandums of understanding (MoUs) and four expressions of interest (EoIs) were exchanged between companies and institutions operating in the sector. These investment pledges are expected to bolster the state’s push to grow research-driven industries and build a more robust ecosystem for innovation, manufacturing, and the commercialisation of life sciences products. The event drew more than 600 delegates and over 45 exhibitors, bringing together industry leaders, researchers, and investors under one roof. Both leading public institutions and private players participated in the conclave, which focused on exploring opportunities in emerging areas such as artificial intelligence, advanced therapies, nutraceuticals, next-generation biologics and scientific research.&nbsp;Also read: <a href="https://www.wionews.com/india-news/supreme-court-special-sunday-sitting-opposition-leaders-detention-delhi-metro-1791646461789">Delhi protest: SC to hear plea against opposition leaders’ detention in special Sunday sitting</a><h3>Kerala's govt backs 'Bio360 Life Sciences Park and SARAL Kerala'</h3>KSIDC Managing Director Snehil Kumar Singh said, "Kerala needed to move beyond manufacturing and strengthen the entire life sciences value chain, from research and development to validation, commercialisation and access to global markets." "The state’s objective was not merely to attract investment but to build an ecosystem where research generates innovation, companies create jobs and new technologies deliver solutions for society," he said. To promote the sector, the government is backing initiatives like the Bio360 Life Sciences Park and SARAL Kerala, alongside investment facilitation measures designed to make the state a more attractive destination for life sciences enterprises. The conclave also underscored the importance of stronger collaboration between research institutions and industry to help turn scientific breakthroughs into commercially viable products. Through this initiative, the state is hoping to spur the growth of new enterprises, build on its existing strengths, and position Kerala as a competitive hub for life sciences research and industrial development.

The event 'Bio Connect 4.0' held for two days concluded on Friday (October 9). During the event, three memorandums of understanding (MoUs) and four expressions of interest (EoIs) were exchanged between companies and institutions operating in the sector.

Kerala has intensified its efforts to establish itself as a leading hub for life sciences and biomedical industries, securing investment pledges worth Rs 713 crore through an international conclave hosted by the state-owned Kerala State Industrial Development Corporation (KSIDC). The event 'Bio Connect 4.0' held for two days concluded on Friday (October 9). During the event, three memorandums of understanding (MoUs) and four expressions of interest (EoIs) were exchanged between companies and institutions operating in the sector. These investment pledges are expected to bolster the state’s push to grow research-driven industries and build a more robust ecosystem for innovation, manufacturing, and the commercialisation of life sciences products. The event drew more than 600 delegates and over 45 exhibitors, bringing together industry leaders, researchers, and investors under one roof. Both leading public institutions and private players participated in the conclave, which focused on exploring opportunities in emerging areas such as artificial intelligence, advanced therapies, nutraceuticals, next-generation biologics and scientific research. Also read: Delhi protest: SC to hear plea against opposition leaders’ detention in special Sunday sitting Kerala's govt backs 'Bio360 Life Sciences Park and SARAL Kerala' KSIDC Managing Director Snehil Kumar Singh said, "Kerala needed to move beyond manufacturing and strengthen the entire life sciences value chain, from research and development to validation, commercialisation and access to global markets." "The state’s objective was not merely to attract investment but to build an ecosystem where research generates innovation, companies create jobs and new technologies deliver solutions for society," he said. To promote the sector, the government is backing initiatives like the Bio360 Life Sciences Park and SARAL Kerala, alongside investment facilitation measures designed to make the state a more attractive destination for life sciences enterprises. The conclave also underscored the importance of stronger collaboration between research institutions and industry to help turn scientific breakthroughs into commercially viable products. Through this initiative, the state is hoping to spur the growth of new enterprises, build on its existing strengths, and position Kerala as a competitive hub for life sciences research and industrial development.

The event 'Bio Connect 4.0' held for two days concluded on Friday (October 9). During the event, three memorandums of understanding (MoUs) and four expressions of interest (EoIs) were exchanged between companies and institutions operating in the sector.

Bio Connect 4.0: Kerala secures Rs 713 crore investment pledges in life sciences

bio-connect-40

Bio Connect 4.0, News on Bio Connect 4.0, stories on Bio Connect 4.0, articles on Bio Connect 4.0, Bio Connect 4.0 stories at Wion, Bio Connect 4.0 news, Bio Connect 4.0 latest news

bio connect-40

Bio Connect 4.0: Kerala secures Rs 713 crore investment pledges in life sciences